1-Benzyl-3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)imidazolidin-2-one

ID: ALA4530528

PubChem CID: 57422491

Max Phase: Preclinical

Molecular Formula: C19H21N5O2

Molecular Weight: 351.41

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1noc(C)c1Cn1cc(N2CCN(Cc3ccccc3)C2=O)cn1

Standard InChI:  InChI=1S/C19H21N5O2/c1-14-18(15(2)26-21-14)13-23-12-17(10-20-23)24-9-8-22(19(24)25)11-16-6-4-3-5-7-16/h3-7,10,12H,8-9,11,13H2,1-2H3

Standard InChI Key:  MDRVGLOFKDNZHI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    2.7858   -3.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6072   -3.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8615   -2.9502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1986   -2.4640    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5357   -2.9502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3047   -4.3915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6432   -2.6946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0909   -4.3927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9078   -4.3083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4530   -4.9203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2041   -4.5888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1196   -3.7718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3163   -3.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9154   -4.9982    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9976   -5.8122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8007   -5.9818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2101   -5.2703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6600   -4.6612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8269   -3.8613    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0227   -5.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5040   -5.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1707   -6.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6512   -7.2515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4647   -7.1652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7954   -6.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3128   -5.7564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  1  0
  1  6  1  0
  3  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 18 19  2  0
 17 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4530528

   1-benzyl-3-(1-((3,5-dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)imidazolidin-2-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 351.41

Molecular Weight (Monoisotopic): 351.1695

AlogP: 2.98

#Rotatable Bonds: 5

Polar Surface Area: 67.40

Molecular Species: NEUTRAL

HBA: 5

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 1.70

CX LogP: 1.59

CX LogD: 1.59

Aromatic Rings: 3

Heavy Atoms: 26

QED Weighted: 0.71

Np Likeness Score: -2.17

References

1. Fotsing JR, Darmohusodo V, Patron AP, Ching BW, Brady T, Arellano M, Chen Q, Davis TJ, Liu H, Servant G, Zhang L, Williams M, Saganich M, Ditschun T, Tachdjian C, Karanewsky DS..  (2020)  Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists.,  63  (9): [PMID:32330040] [10.1021/acs.jmedchem.0c00388]

Source

Source(1):

• Scientific Literature